This Article  • Full text  • PDF  • Original Article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letter  • Similar articles in this journal  Topic Collections  • Journalology/ Peer Review/ Authorship  • Conflict of Interest  • Neurology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Roger N. Rosenberg, MD, Editor

	Since this article does not have an abstract, we have provided the first 117 words of the full text and any section headings.

In the Archives of Neurology article "A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials" (2007;64[9]:1323-1329), John Harrison, CPsychol, PhD, did not fully disclose his financial conflict of interest with Elan Pharmaceuticals and Wyeth Research. When questioned, Harrison initially claimed he made a full disclosure to the Archives that he was a paid consultant to both companies and did not know why his consulting status was not mentioned in the journal. He now recants that claim and accepts responsibility in his accompanying letter and apology, saying the failure to disclose his relationship with Wyeth Pharmaceuticals and Elan Research "was not the fault of the Archives or any of its staff."

Arch Neurol. 2008;65(7):992.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials
John Harrison, Sonia L. Minassian, Lisa Jenkins, Ronald S. Black, Martin Koller, and Michael Grundman
Arch Neurol. 2007;64(9):1323-1329.
ABSTRACT | FULL TEXT  

RELATED LETTER

Notice of Failure to Disclose Financial Interest: "A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials" (Arch Neurol. 2007;64[9]:1323-1329)
John Harrison
Arch Neurol. 2008;65(7):992.
EXTRACT | FULL TEXT